Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.93 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.93 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.93 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.93 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.93 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | PPARG | P37231 | 7/20 | 0.55 |
| ▸ | PPARD | Q03181 | 7/20 | 0.55 |
| ▸ | PPARA | Q07869 | 7/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL2503 | 0.96 | — | — | |
| Butyric Acid SCHEMBL1330379 | 0.96 | — | — | |
| Butyric Acid SCHEMBL991717 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1332215 | 0.96 | — | — | |
| Butyric Acid SCHEMBL339305 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL8458708 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL5703921 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL8457839 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL20678495 | 0.96 | — | — | |
| Butyric Acid SCHEMBL4446516 | 0.96 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298350-A2 | Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders | Perrine, Susan P. (US) | 2011-03-23 | — | — | EP | claimed |
| EP-1886677-A1 | Use of an inducing agent for the treatment of blood, viral and cellular disorders | Perrine, Susan P. (US) | 2008-02-13 | — | — | EP | claimed |
| EP-1611885-A1 | Use of an inducing agent for the treatment of blood, viral and cellular disorders | Perrine, Susan P. (US) | 2006-01-04 | — | — | EP | claimed |
| JP-2001527517-A | — | — | 2001-12-25 | — | — | JP | claimed |
| EP-0969869-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | Perrine, Susan P. (US) | 2000-01-12 | — | — | EP | claimed |
| US-5939456-A | METHOD OF STIMULATING THE EXPRESSION OF A GLOBIN PROTEIN, OR THE PROLIFERATION OR DEVELOPMENT OF ERYTHROID CELLS, MYELOID CELLS OR MEGAKARYOCYTIC CELLS FOR TREATING A DISORDER SELECTED FROM THE GROUP CONSISTING OF CYTOPENIA, AN ANEMIA AND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1999-08-17 | — | — | US | claimed |
| WO-1998004290-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | PERRINE SUSAN P (US) | 1998-02-05 | — | — | WO | claimed |
| CN-119547896-A | Synbiotic mixture capable of improving metabolic homeostasis of organism and intestinal microecology and preparation method and application thereof | 贵州大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-118058474-A | New use of brine polysaccharide | 天津科技大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-117242037-A | Separation method | 欧佩克修复技术有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-117210517-A | Butyrylated galacto-oligosaccharide and preparation and application thereof | 暨南大学 | 2023-12-12 | — | — | CN | disclosed |
| US-20230346788-A1 | METHODS FOR TREATING VIRAL DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-02 | — | — | US | disclosed |
| US-11701363-B2 | Methods for treating viral disorders | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-07-18 | — | — | US | disclosed |
| US-20010034367-A1 | Compositions and methods for the treatment of cystic fibrosis | UNIVERSITY OF WASHINGTON | 2001-10-25 | — | — | US | disclosed |
| EP-0969869-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | Perrine, Susan P. (US) | 2000-01-12 | — | — | EP | disclosed |
| US-5968682-A | Coated metal sheet for battery containers, battery containers and batteries produced thereof | TOYO KOHAN CO., LTD. (JP) | 1999-10-19 | — | — | US | disclosed |
| WO-1999040883-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | FALLER DOUGLAS V (US) | 1999-08-19 | — | — | WO | disclosed |
| US-5939456-A | METHOD OF STIMULATING THE EXPRESSION OF A GLOBIN PROTEIN, OR THE PROLIFERATION OR DEVELOPMENT OF ERYTHROID CELLS, MYELOID CELLS OR MEGAKARYOCYTIC CELLS FOR TREATING A DISORDER SELECTED FROM THE GROUP CONSISTING OF CYTOPENIA, AN ANEMIA AND | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1999-08-17 | — | — | US | disclosed |
| US-5792553-A | FOR ALKALINE-MANGANESE BATTERIES; THERMOPLASTIC RESIN COATED METAL SHEETS | TOYO KOHAN CO., LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| WO-1998004290-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | PERRINE SUSAN P (US) | 1998-02-05 | — | — | WO | disclosed |